@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-RBW9X9MD-F
  skos:prefLabel "Enzyme Activators"@en, "Activateurs d'enzymes"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-PZ03ZWM2-7 .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PZ03ZWM2-7
  mesh:allowableQualifier jvr:-Q3979798-W, jvr:-SBNWSM1T-R, jvr:-XV06LPML-W, jvr:-CB30NGKB-3, jvr:-H7K65Q8S-Z, jvr:-NKM836P1-M, jvr:-NFTHND7Q-8, jvr:-WK5F724J-1, jvr:-HQRFT0C6-B, jvr:-BT300B3G-Q, jvr:-D0F21513-5, jvr:-NB0XHT3S-N, jvr:-S0CS1X5R-5, jvr:-THHNVC7V-3, jvr:-TJHVZCRZ-0, jvr:-FWD2BGQ0-9, jvr:-G30ZJ446-J, jvr:-NHL3D2X0-S, jvr:-T9HQD7ST-J, jvr:-W6SQV79N-S, jvr:-L6C0XPHT-4, jvr:-R3QWLHRG-V ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D065097> ;
  skos:inScheme jvr: ;
  a skos:Concept, mesh:Descriptor ;
  skos:prefLabel "Carbamoyl Phosphate Synthetase I Activators"@en, "Activateurs de la Carbamoyl phosphate synthetase I"@fr ;
  skos:broader jvr:-RBW9X9MD-F ;
  dc:modified "2014-06-24"^^xsd:date ;
  skos:definition "Substances and drugs that stimulate the synthesis or increase the activity of CARBAMOYL PHOSPHATE SYNTHETASE I. Drugs in this class of compounds have been used to treat the genetic disorder, CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE."@en ;
  dc:established "2015-01-01"^^xsd:date ;
  skos:altLabel "Activateurs de la Carbamoyl-Phosphate Synthase (Ammonia)"@fr, "Carbamoyl-Phosphate Synthase (Ammonia) Activators"@en ;
  dc:created "2014-06-26"^^xsd:date .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .